Immunosuppressive Agents: all 5,940 studies that test it
Page 33 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1DCompletedNCT03632759Early Phase 1
- A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With GliomasWithdrawnNCT03632317Phase 2
- Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSCompletedNCT03632187Phase 3
- ATG-F VS ATG for the Prevention of GVHDStatus unknownNCT03631563Phase 2/3
- Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin AnalogueStatus unknownNCT03629847Phase 1/2
- A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid TumorsCompletedNCT03627741Phase 1
- Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma PatientsStatus unknownNCT03617432Phase 2
- Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active, not recruitingNCT03616587Phase 1
- Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic DermatitisCompletedNCT03614221Phase 2
- A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWithdrawnNCT03608501Phase 2
- Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control TrialStatus unknownNCT03603548Not applicable
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWithdrawnNCT03602898Phase 2
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaStatus unknownNCT03602131Phase 2
- The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing ChemotherapyStatus unknownNCT03601871Not applicable
- A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E MutationStatus unknownNCT03585686Phase 2
- Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsTerminatedNCT03585465Phase 1/2
- Efficacy and Safety of Sirolimus to Vascular AnomaliesCompletedNCT03583307Not applicable
- Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney TransplantationCompletedNCT03582878Phase 4
- Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway DeficiencyStatus unknownNCT03580239Phase 3
- CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
- Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation TherapyTerminatedNCT03578432Early Phase 1
- Liver Transplantation With Tregs at MGHCompletedNCT03577431Phase 1/2
- Treatment With Leflunomide in Patients With Polymyalgia RheumaticaStatus unknownNCT03576794Phase 3
- BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)Active, not recruitingNCT03576378Phase 1/2
- Anti-inflammatory Treatment for Inactive Takayasu ArteritisStatus unknownNCT03550781Phase 2/3
- Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)Status unknownNCT03549663Not applicable
- Tacrolimus Treatment for Refractory PRCAStatus unknownNCT03540472Phase 4
- RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis FactorCompletedNCT03536039Phase 2
- Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia AreataCompletedNCT03535233Phase 4
- T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic AnemiaActive, not recruitingNCT03531736Phase 1
- Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast CancerCompletedNCT03518242Phase 1
- Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMITerminatedNCT03516903Phase 2/3
- Tolerance by Engaging Antigen During Cellular HomeostasisCompletedNCT03504241Phase 1
- Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in BangladeshStatus unknownNCT03504072Phase 4
- Sirolimus-based Immunosuppression Treatment Regimen for Liver TransplantationStatus unknownNCT03500848Phase 2/3
- Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and LeiomyomatosisStatus unknownNCT03500367Phase 4
- Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous SystemCompletedNCT03495960Phase 2
- Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)CompletedNCT03492658Phase 4
- CYCLONES - CYClophosphamide LOw Dose and No Extra SteroidTerminatedNCT03492255Not applicable
- Epacadostat, Cladribine and Cytarabine (ECC) in AMLWithdrawnNCT03491579Phase 1
- Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)Active, not recruitingNCT03477500Phase 3
- Phase 1 Food Effect Study for Alicaforsen TabletsCompletedNCT03473626Phase 1
- Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant RecipientsStatus unknownNCT03470961Phase 4
- Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid LeukemiaActive, not recruitingNCT03467386Phase 1
- CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLActive, not recruitingNCT03467256Phase 1/2
- A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy SubjectsCompletedNCT03466567Phase 1
- A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant PatientsCompletedNCT03465969Phase 4
- OPTImization of the Dose of tacroliMUS by Bayesian PredictionCompletedNCT03465410Phase 4
- A Novel Combined Therapy for Refractory Vernal KeratoconjunctivitisCompletedNCT03464435Phase 4
- Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With MyelomaTerminatedNCT03448978Phase 1
- Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441048Phase 1
- Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant RecipientsStatus unknownNCT03438773Phase 1
- AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin LymphomaActive, not recruitingNCT03434769Phase 1
- Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid TreatmentStatus unknownNCT03431961Not applicable
- Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisCompletedNCT03426969Early Phase 1
- To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant RecipientsCompletedNCT03423225Phase 4
- Stem Cell Transplant in Patients With Severe Sickle Cell DiseaseTerminatedNCT03421756Early Phase 1
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal TransplantsCompletedNCT03415750Phase 4
- Thoracic Epidural Analgesia in Flail ChestStatus unknownNCT03413059Phase 2/3
- Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingStatus unknownNCT03412643Phase 2
- Sjogrens Syndrome Measured by UltrasoundStatus unknownNCT03411850Phase 2
- Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.CompletedNCT03410654Early Phase 1
- Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe PsoriasisStatus unknownNCT03408756Phase 4
- Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )Status unknownNCT03403140Phase 3
- Corneal Tear Film Imaging of the Cornea Before and After Restasis TherapyStatus unknownNCT03403023Not applicable
- Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for TransplantationCompletedNCT03402295Phase 3
- Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCTStatus unknownNCT03395860Phase 2
- Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCTStatus unknownNCT03385096Phase 2/3
- CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384225Phase 3
- CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384212Phase 3
- Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ SyndromeCompletedNCT03383380Phase 1/2
- Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant RecipientsTerminatedNCT03380936Early Phase 1
- Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple MyelomaStatus unknownNCT03380039Not applicable
- BENDITA BEnznidazole New Doses Improved Treatment and AssociationsStatus unknownNCT03378661Phase 2
- A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different ProcessesCompletedNCT03375138Phase 1
- Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the ElderlyActive, not recruitingNCT03373903Phase 2
- Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing RegimenCompletedNCT03373227Phase 2
- To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With CorticosteroidsCompletedNCT03371667Phase 3
- Add-on Methotrexate for the Treatment of SchizophreniaStatus unknownNCT03369795Phase 2
- A Pilot-Study of Sirolimus for the Treatment of Systemic SclerosisStatus unknownNCT03365869Phase 2
- Efficacy of Intralesional Triamcinolone Injection in the Treatment of VitiligoStatus unknownNCT03365141Not applicable
- Sirolimus Treatment for Refractory PRCACompletedNCT03364764Phase 4
- Rapamycin Treatment for ALSCompletedNCT03359538Phase 2
- Effectivness of Topical Tacrolimus Monotherapy in Patients With VitiligoStatus unknownNCT03358082Phase 1/2
- A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)CompletedNCT03355794Phase 1
- Pharmacokinetics of Tacrolimus in ChildrenCompletedNCT03347357Phase 4
- Fingolimod Versus Dimethyl-fumarate in Multiple SclerosisTerminatedNCT03345940Phase 4
- EGFR Mutation Positive NSCLC Patients With Gefitinib and ThalidomideStatus unknownNCT03341494Phase 2
- Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic LeukemiaStatus unknownNCT03339700Phase 2
- Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCTStatus unknownNCT03336632Phase 2
- Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple MyelomaStatus unknownNCT03336073Phase 2
- Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid ArthritisCompletedNCT03332719Phase 3
- Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerCompletedNCT03332576Phase 1
- Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/LymphomaCompletedNCT03328104Phase 1
- Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis PatientsCompletedNCT03327116Not applicable
- Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)CompletedNCT03324373Phase 1
- Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Status unknownNCT03321890Phase 2
- Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic PatientsWithdrawnNCT03319784Phase 4
- Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT03318419Phase 2